Cyclic pyranopterin monophosphate is a precursor to molybdenum cofactor, which is required for the enzyme activity of sulfite oxidase, xanthine dehydrogenase/oxidase, and aldehyde oxidase. The drug is being investigated in severe molybdenum cofactor deficiency type A. In a clinical study, intravenous administration of the drug resulted in greatly improved neurodevelopmental outcome when started sufficiently early.
Approval Year
| Substance Class |
Concept
|
| Record UNII |
X41B5W735T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2301083-34-9
Created by
admin on Mon Oct 21 20:32:23 UTC 2019 , Edited by admin on Mon Oct 21 20:32:23 UTC 2019
|
PRIMARY | |||
|
SUB197141
Created by
admin on Mon Oct 21 20:32:24 UTC 2019 , Edited by admin on Mon Oct 21 20:32:24 UTC 2019
|
PRIMARY |
This is a non-substance concept
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
This is a non-substance concept